P1152: DEPTH OF METABOLIC RESPONSE AT INTERIM PET AND SURVIVAL OUTCOMES AMONG PATIENTS WITH PRIMARY REFRACTORY OR EARLY RELAPSING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

• Allison Bock,
• Raphael Mwangi,
• Fatemeh Ataei,
• Matthew Thorpe,
• Matthew Maurer,
• Josh Pritchett,
• Jacob Shreve,
• Jonas Paludo,
• James Cerhan,
• Arushi Khurana,
• Thomas Witzig,
• Thomas Habermann,
• Yucai Wang,
• Grzegorz S. Nowakowski,
• Jason Young

Affiliations

Allison Bock

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Raphael Mwangi

2 Mayo Clinic, Quantitative Health Sciences, United States

Fatemeh Ataei

3 Mayo Clinic, Radiology, Jacksonville, United States

Matthew Thorpe

4 Mayo Clinic, Radiology, Rochester, United States

Matthew Maurer

2 Mayo Clinic, Quantitative Health Sciences, United States

Josh Pritchett

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Jacob Shreve

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Jonas Paludo

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

James Cerhan

2 Mayo Clinic, Quantitative Health Sciences, United States

Arushi Khurana

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Thomas Witzig

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Thomas Habermann

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Yucai Wang

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Grzegorz S. Nowakowski

1 Mayo Clinic, Medicine; Division of Hematology, Rochester, United States

Jason Young

3 Mayo Clinic, Radiology, Jacksonville, United States